Conformal Prediction for Uncertainty Quantification and Reliable HER2 Status Classification in Breast Cancer IHC Images
Accurate assessment of Human Epidermal growth factor receptor 2 (HER2) status in breast cancer is crucial for determining treatment eligibility for targeted therapies. Although machine learning approaches have shown promise in automating HER2 status classification from immunohistochemistry (IHC) ima...
Saved in:
| Main Authors: | Surayuth Pintawong, Shanop Shuangshoti, Tikamporn Jitpasutham, Somruethai Shuangshoti, Kulachet Wiwatwarayos, Thananop Kobchaisawat, Thanarat H. Chalidabhongse |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IEEE
2025-01-01
|
| Series: | IEEE Access |
| Subjects: | |
| Online Access: | https://ieeexplore.ieee.org/document/10933960/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Accuracy of human epidermal growth factor receptor 2 (HER2) immunohistochemistry scoring by pathologists in breast cancer, including the HER2-low cutoff
by: Agata Wróbel, et al.
Published: (2025-04-01) -
HER2-IHC-40x: A high-resolution histopathology dataset for HER2 IHC scoring in breast cancerZenodo
by: Md Serajun Nabi, et al.
Published: (2025-10-01) -
Interobserver variability in her2 immunohistochemistry analysis and its clinical implications with the advent of the HER2-low category
by: Ana Catharina Joaquim, et al.
Published: (2025-08-01) -
Prevalence and Clinicopathologic Features of HER2 Overexpression in Endocervical Adenocarcinoma
by: Niusha Momeni, et al.
Published: (2025-07-01) -
Dual-targeting and steric hindrance resolution in HER2 IHC: a novel approach to improve diagnostic sensitivity
by: Li Luo, et al.
Published: (2025-07-01)